Evidence map›Paper›PMID 29615487›Full record

SynthesisGut2019

Comparison of prognostic models to predict the occurrence of colorectal cancer in asymptomatic individuals: a systematic literature review and external validation in the EPIC and UK Biobank prospective cohort studies.

Todd Smith, David C Muller, Karel G M Moons, Amanda J Cross, Mattias Johansson, Pietro Ferrari, Guy Fagherazzi, Petra H M Peeters, Gianluca Severi, Anika Hüsing and 27 more

Open access · hybridAbstract readComparative StudySystematic ReviewValidation Study
In one paragraph

Synthesis in Gut, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 5 pooled it
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 5 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Circulating Sex Hormone Levels and Colon Cancer Risk in Men: A Nested Case-Control Study and Meta-Analysis.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Validation of a Colorectal Cancer Risk Prediction Model in US Black Women.Cancer prevention research (Philadelphia, Pa.) · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 20 institutions in 11 countries.

Todd SmithDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
David C MullerDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Karel G M MoonsJulius Center for Health Sciences and Primary Care, Umc Utrecht, Utrecht University, Utrecht, The Netherlands.
Amanda J CrossDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Mattias JohanssonInternational Agency for Research on Cancer (IARC), Genetic Epidemiology Group, Lyon, France.
Pietro FerrariNutritional Methodology and Biostatistics Group (NMB), International Agency for Research on Cancer, Lyon, France.
Guy FagherazziInserm U1018, Gustave Roussy, Universite Paris-Sud, Villejuif, France.
Petra H M PeetersDepartment of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Gianluca SeveriInserm U1018, Gustave Roussy, Universite Paris-Sud, Villejuif, France.
Anika HüsingDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Rudolf KaaksDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Anne TjonnelandDanish Cancer Society Research Center, Copenhagen, Denmark.
Anja OlsenDanish Cancer Society Research Center, Copenhagen, Denmark.
Kim OvervadDepartment of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.
Catalina BonetCatalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Barcelona, Spain.
Miguel Rodriguez-BarrancoCIBER de Epidemiologia y Salud Publica (CIBERESP), Escuela Andaluza de Salud Publica, Madrid, Spain.
Jose Maria HuertaMurcia Regional Health Council, IMIB-Arrixaca, CIBER de Epidemiologia y Salud Publica (CIBERESP), Madrid, Spain.
Aurelio Barricarte GurreaNavarra Public Health Institute, CIBER de Epidemiologia y Salud Publica (CIBERESP), Madrid, Spain.
Kathryn E BradburyCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.ORCID 0000-0003-3345-7333
Antonia TrichopoulouHellenic Health Foundation, Athens, Greece.
Christina BamiaHellenic Health Foundation, Athens, Greece.
Philippos OrfanosUnit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, WHO Collaborating Center for Nutrition and Health, National and Kapodistrian University of Athens, Athens, Greece.
Domenico PalliCancer Risk Factors and Life-Style Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy.
Valeria PalaEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Paolo VineisItalian Institute for Genomic Medicine, Turin, Italy.
Bas Bueno-de-MesquitaDepartment for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Bodil OhlssonDepartment of Internal Medicine, Lund University, Skane University Hospital, Malmo, Sweden.
Sophia HarlidDepartment of Radiation Sciences, Oncology, Umea University, Umea, Sweden.
Bethany Van GuelpenDepartment of Radiation Sciences, Oncology, Umea University, Umea, Sweden.
Guri SkeieDepartment of Community Medicine, Faculty of Health Sciences, University of Tromso, The Arctic University of Norway, Tromso, Norway.
Elisabete WeiderpassDepartment of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.
Mazda JenabNutritional Epidemiology Group, International Agency for Research on Cancer, Lyon, France.
Neil MurphyNutritional Epidemiology Group, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0003-3347-8249
Elio RiboliDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Marc J GunterNutritional Epidemiology Group, International Agency for Research on Cancer, Lyon, France.
Krasimira Jekova AleksandrovaNutrition, Immunity and Metabolism Start-up Lab, Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbrucke, Germany.
Ioanna TzoulakiDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Centre international de recherche sur le cancer · FRImperial College London · GBCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESDanish Cancer Society · DKGerman Cancer Research Center · DEHellenic Health Foundation · GRUmeå University · SEUniversité Paris-Sud · FRUtrecht University · NLAarhus University · DKCancer Registry of Norway · NOFondazione IRCCS Istituto Nazionale dei Tumori · ITGerman Institute of Human Nutrition · DEInstitut d'Investigació Biomédica de Bellvitge · ESInstituto de Salud Pública de Navarra · ESItalian institute for Genomic Medicine · ITLund University · SENational and Kapodistrian University of Athens · GRNational Institute for Public Health and the Environment · NLPrevention Institute · US

Funding

Cancer Research UK 14136Cancer Research UK 16491Cancer Research UK 24390Cancer Research UK 25004Cancer Research UK C570/A16491Cancer Research UK C57955/A24390Cancer Research UK C8221/A19170Medical Research Council 1000143Medical Research Council G0401527Medical Research Council G1000143Medical Research Council MC_PC_17228Medical Research Council MC_QA137853Medical Research Council MR/M012190/1Medical Research Council MR/M501712/1Medical Research Council MR/N003284/1World Health Organization 001
6 · The paper itself

Abstract

objectiveTo systematically identify and validate published colorectal cancer risk prediction models that do not require invasive testing in two large population-based prospective cohorts.

designModels were identified through an update of a published systematic review and validated in the European Prospective Investigation into Cancer and Nutrition (EPIC) and the UK Biobank. The performance of the models to predict the occurrence of colorectal cancer within 5 or 10 years after study enrolment was assessed by discrimination (C-statistic) and calibration (plots of observed vs predicted probability).

resultsThe systematic review and its update identified 16 models from 8 publications (8 colorectal, 5 colon and 3 rectal). The number of participants included in each model validation ranged from 41 587 to 396 515, and the number of cases ranged from 115 to 1781. Eligible and ineligible participants across the models were largely comparable. Calibration of the models, where assessable, was very good and further improved by recalibration. The C-statistics of the models were largely similar between validation cohorts with the highest values achieved being 0.70 (95% CI 0.68 to 0.72) in the UK Biobank and 0.71 (95% CI 0.67 to 0.74) in EPIC.

conclusionSeveral of these non-invasive models exhibited good calibration and discrimination within both external validation populations and are therefore potentially suitable candidates for the facilitation of risk stratification in population-based colorectal screening programmes. Future work should both evaluate this potential, through modelling and impact studies, and ascertain if further enhancement in their performance can be obtained.

Indexed as

Asymptomatic DiseasesPredictive Value of TestsBiological Specimen BanksColorectal NeoplasmsEarly Detection of CancerEuropeHumansPrognosisRisk AssessmentRisk FactorsUnited Kingdomcancer preventioncolorectal cancercolorectal cancer screeningepidemiologymedical statistics

Identifiers

PMID29615487
PMCPMC6580880
OpenAlexW2795555785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.